FDA approves Abiomed's blood pump device

(Reuters) - The U.S. Food and Drug Administration said it approved Abiomed Inc's miniature blood pump system that maintains heart function and circulation during high-risk procedures. The device, Impella 2.5 System, can be used during angioplasty and stenting, the regulator said on Monday. (http://1.usa.gov/1xWUGfq) Angioplasty and stenting are procedures used to re-open arteries in the heart that are blocked due to coronary artery disease. (Reporting by Amrutha Penumudi in Bengaluru; Editing by Sriraj Kalluvila) March 23, 2015 at 05:52PM

via Lazahealth.org